T7	Treatment 151 193	1 week after the fourth dose of adalimumab
T9	Effect 44 149	jaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat
T10	Subject 0 28	A 65-year-old female patient
T11	Age 2 13	65-year-old
T12	Gender 14 20	female
T13	Drug 183 193	adalimumab
T14	Time_elapsed 151 163	1 week after
T15	Dosage 168 179	fourth dose
T8	Adverse_event 29 38	presented
E1	Adverse_event:T8